Cohort Profile: The Assessing Economic Transitions (ASSET) Study-A Community-Based Mixed-Methods Study of Economic Engagement among Inner-City Residents
Richardson L, Minh A, McCormack D, Laing A, Barbic S, Hayashi K, Milloy MJ, Huyser KR, Leahy K, Li J; ASSET Study Team., Int J Environ Res Public Health. 2022
Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report
MacAusland-Berg J, Wiebe A, Marwah R, Halpape K., Can J Pain. 2022
Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice
Hodgins DC, Budd M, Czukar G, Dubreucq S, Jackson LA, Rush B, Quilty LC, Adams D, Cameron Wild T., Can J Psychiatry. 2022
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada
Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N., Canada. Int J Drug Policy. 2022
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform
Moallef S, Dale L, Homayra F, Zonneveld C, Milloy MJ, Nosyk B, Hayashi K; Vancouver Area Network of Drug Users., J Subst Abuse Treat. 2022
Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids
Juwono S, Milloy MJ, Choi J, Fairbairn N, Nolan S, Socías ME., AIDS. 2022
HIV and Incarceration: Implications for HIV-Positive People Who Use Illicit Drugs During a Seek, Test, Treat, and Retain Initiative in Canada
Blumenkrans E, Hamilton J, Mohd Salleh NA, Kaida A, Small W, Barrios R, Milloy MJ., J Correct Health Care. 2022
Retrospective Cohort Study Examining the Correlates of Reported Lifetime Stimulant Use in Persons Diagnosed With Infectious Syphilis in Alberta, Canada, 2018 to 2019
Raval M, Gratrix J, Plitt S, Niruban J, Smyczek P, Dong K, Singh AE., Sex Transm Dis. 2022
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study
Gehring ND, Speed KA, Wild TC, Pauly B, Salvalaggio G, Hyshka E., Int J Drug Policy. 2022
Utilisation problématique des opioïdes : une revue de littérature d’analyse des profils
Archambault L., Bertrand K., Perreault M., Toxicomanie : traitement, prévention et politique, 2022
